跳至主要内容
临床试验/NCT02418156
NCT02418156已完成不适用

A Post Market Observational Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction

Aziyo Biologics, Inc.0 个研究点目标入组 38 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
38
主要终点
Device-Related Adverse Events

研究概览

简要总结

To gather information on the use of CorMatrix ECM for Vascular Repair in the reconstruction of the femoral artery.

详细描述

OBJECTIVE The objective of the study is to actively gather additional information on the use of CorMatrix ECM for vascular repair in the reconstruction of the femoral artery. The CorMatrix ECM for Vascular Repair may be used for patch closure of vessels, as a pledget, or for suture line buttressing when repairing peripheral vessels.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subjects must be undergoing femoral arterial reconstruction with patch angioplasty closure
  • Surgeon intends to use CorMatrix ECM per FDA cleared Indications for Use
  • Subject possesses ability to provide informed consent
  • Subject expresses understanding and willingness to fulfill all expected requirements of protocol

排除标准

  • Known sensitivity to porcine material

结局指标

主要结局

Device-Related Adverse Events

时间窗: Up to 12 months follow-up

Proportion of patients experiencing device related adverse events.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验